The global apheresis market was valued at USD 2,990 million in 2022 and is forecast to reach USD 8,960 million by 2032, expanding at an impressive CAGR of 11.6% from 2022 to 2032. This growth follows a robust performance between 2017 and 2021, when the market expanded at a CAGR of 10.3%, highlighting strong momentum in demand for blood component separation procedures across healthcare systems globally.

Key Growth Drivers and Trends

Apheresis is a specialized procedure that involves extracting blood from a donor, separating specific components such as plasma or platelets, and then reinfusing the remaining elements back into the bloodstream. Increasing incidence of chronic and blood-related diseases, coupled with rising demand for effective treatments such as plasma-derived medicines, is a core growth catalyst for this market.

Technological advancements in centrifugation and membrane filtration technologies and increasing automation in apheresis machines have made procedures faster and more efficient, thus fueling widespread adoption. In addition, government-backed reimbursement schemes in developed regions, notably Medicare and Medicaid in the U.S., are encouraging the use of advanced apheresis therapies.

Browse Full Report: https://www.factmr.com/report/4352/apheresis-market

Regional Market Outlook

North America dominated the global apheresis market in 2022, contributing 45.5% of the market share, driven by a highly developed healthcare infrastructure, increased investment in R&D, and the rising demand for plasma-based therapies. With an estimated CAGR of around 10%, the region continues to lead due to its extensive clinical research ecosystem and robust funding support for healthcare services.

On the other hand, the Asia Pacific region is anticipated to register the highest CAGR during the forecast period. The surging geriatric population, increasing chronic illness cases such as autoimmune diseases and cancers, and rising organ transplantation procedures are driving demand in countries like China, Japan, and India. Japan and China, in particular, are projected to hold more than one-fifth of the regional market, driven by technological innovation and rising healthcare access.

Application and Procedure Insights

Among the application segments, neurology leads with a historical CAGR of 11.2%, and a projected CAGR of 10.9% during the forecast period. The increasing prevalence of neurological disorders such as multiple sclerosis (MS) and Guillain-Barre syndrome has driven apheresis demand due to its efficacy in reducing neurological inflammation.

In terms of procedure type, plasmapheresis continues to hold the largest market share. It registered a CAGR of 11.1% from 2017 to 2021 and is projected to grow at 10.7% through 2032. Its popularity stems from widespread application in treating renal, metabolic, hematologic, and neurological disorders.

Opportunities and Challenges

The market holds significant opportunities with the introduction of new therapies, such as stem cell treatments, immunoglobulin therapies, and other biopharmaceutical innovations. Increasing public participation in blood donation drives and the popularity of preventive healthcare are further propelling growth.

However, a lack of skilled professionals and high treatment costs—especially in developing regions—pose a potential barrier. Despite technological advancements, the shortage of trained operators raises operational costs, while affordability remains a concern in cost-sensitive markets.

Want a Sample Before Buying? Download Free Sample: https://www.factmr.com/connectus/sample?flag=S&rep_id=4352

Competitive Landscape

The apheresis market is highly competitive, with several leading players constantly innovating to improve efficiency, reduce treatment time, and integrate smart technologies. Prominent companies include:

• Terumo Corporation
• Fresenius Kabi AG
• B. Braun Melsungen AG
• NIKKISO Co., Ltd.
• Asahi Kasei Medical Co. Ltd.
• Haemonetics Corporation
• Cerus Corporation
• Medica S.p.A.
• Kawasumi Laboratories Inc.
• Therakos Inc.

Key strategic moves include partnerships with hospitals, product launches, and infrastructure expansions. For instance, Fresenius Kabi expanded its transfusion and apheresis disposables plant in the Dominican Republic to meet rising demand, while Haemonetics partnered with Epic to integrate its SafeTrace Tx® blood bank system into Epic’s hospital networks globally.

Start-ups like Bioelettronica are also reshaping the landscape with smart devices like the Biomixer BM330, designed for better data integration and workflow customization in blood collection centers.

Segment-Wise Outlook

By Product:

• Devices
• Disposables

By Application:

• Neurology
• Renal Diseases
• Hematology
• Cardiovascular Diseases
• Autoimmune Diseases
• Cancer
• Others

By Procedure:

• Plasmapheresis
• Photopheresis
• Plateletpheresis
• LDL Apheresis
• Leukapheresis
• Erythrocytapheresis
• Others

By Technology:

• Centrifugation
• Membrane Filtration

By End User:

• Hospitals
• Blood Collection Centers (Public & Private)

By Region:

• North America
• Europe
• Asia Pacific
• Latin America
• Middle East & Africa

Check out More Related Studies Published by Fact.MR Research:

Fatliquoring agents Market: https://www.factmr.com/report/5040/fatliquoring-agents-market

Palmitoyl Chloride Market: https://www.factmr.com/report/5046/palmitoyl-chloride-market

Undecanoyl Chloride Market: https://www.factmr.com/report/5052/undecanoyl-chloride-market

Tar oil Market: https://www.factmr.com/report/5062/tar-oil-market

Deep-V Boat Market: https://www.factmr.com/report/5067/deepv-boat-market

About Us:

Fact.MR is a distinguished market research company renowned for its comprehensive market reports and invaluable business insights. As a prominent player in business intelligence, we deliver deep analysis, uncovering market trends, growth paths, and competitive landscapes. Renowned for its commitment to accuracy and reliability, we empower businesses with crucial data and strategic recommendations, facilitating informed decision-making and enhancing market positioning.

Contact:
US Sales Office:
11140 Rockville Pike
Suite 400
Rockville, MD 20852
United States
Tel: +1 (628) 251-1583
Sales Team : sales@factmr.com
Follow Us: LinkedIn | Twitter | Blog